Jan. 17, 2025 – Medicare will negotiate the prices of weight loss drugs Wegovy and Ozempic with drug companies, a move that could create big savings for seniors who take the drugs, the Biden ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Danish drugmaker Novo Nordisk reported fourth quarter and full year 2024 earnings Wednesday, beating Wall Street's ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Wegovy’s list price in the U.S. is over $1,300 for a month’s supply. It is five times the price in Canada ($265) and 14 times the price in Britain ($92). The right-wing argues, as Project 2025 puts it ...

Its weight-loss drug policy would fall to Trump's pick for health secretary, Robert F Kennedy Jr, and Mehmet Oz, Trump's ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

"Wegovy is still the household name ... The drugmaker could also explain how it plans to promote Zepbound to older Americans ...